These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices]. Esquivel López A, López Fuertes F, Perches Vega A, Salgado-Escobar JL. Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774 [No Abstract] [Full Text] [Related]
5. [Prevention of hemorrhage from esophageal varices in patients with liver cirrhosis by administration of propranolol]. López Fuerte F, Cárdenas Rojas JA, Esquivel López A, Perches Vega A. Rev Gastroenterol Mex; 1986; 51(4):187-90. PubMed ID: 3502507 [No Abstract] [Full Text] [Related]
6. Long term effects of propranolol on portal pressure in cirrhotic patients. Orban-Schiopu AM, Popescu CR. Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376 [Abstract] [Full Text] [Related]
7. Drug therapy of portal hypertension due to cirrhosis. Benhamou JP, Lebrec D. Semin Liver Dis; 1982 Aug; 2(3):227-32. PubMed ID: 6129706 [No Abstract] [Full Text] [Related]
8. [Rheohepatographic assessment of the therapeutic effects of propranolol on portal hypertension]. Wu XN. Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):411-3, 446. PubMed ID: 3938325 [No Abstract] [Full Text] [Related]
9. [The long-term effect of molsidomine on frequency of hemorrhage, portal and cardiac hemodynamics in patients with liver cirrhosis--a pilot study]. Hüppe D, Jäger D, Tromm A, Barmeyer J, May B. Leber Magen Darm; 1993 May; 23(3):114-8, 121-2. PubMed ID: 8326815 [Abstract] [Full Text] [Related]
10. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis. Bizer LS. Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791 [Abstract] [Full Text] [Related]
11. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers. Hernández-Gea V, Aracil C, Colomo A, Garupera I, Poca M, Torras X, Miñana J, Guarner C, Villanueva C. Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252 [Abstract] [Full Text] [Related]
12. Preventing the development of varices in cirrhosis. Garcia-Tsao G. J Clin Gastroenterol; 2007 Mar; 41 Suppl 3():S300-4. PubMed ID: 17975480 [Abstract] [Full Text] [Related]
15. [The effect of propranolol on portal hypertension]. Kovacević N, Tomić D, Perisić-Savić M, Grbić R. Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814 [Abstract] [Full Text] [Related]
16. [Correction of portal hypertension and renal dysfunction with help of nebivolol and lizinopril in patients with hepatic cirrhosis]. Fedulenkova LV. Eksp Klin Gastroenterol; 2009 Jun; (5):130-7. PubMed ID: 20201315 [Abstract] [Full Text] [Related]
17. [Medical treatment of hemorrhage in portal hypertension of the cirrhotic patient using propanolol]. Chevrel B. Med Chir Dig; 1982 Jun; 11(1):69-70, 73-5. PubMed ID: 6979665 [No Abstract] [Full Text] [Related]
18. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis]. Vorob'ev LP, Maev IV, Andreev NG. Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666 [Abstract] [Full Text] [Related]
19. The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Sharma P, Kumar A, Jha S, Mishra SR, Sharma BC, Sarin SK. Aliment Pharmacol Ther; 2010 Jul; 32(1):105-12. PubMed ID: 20345511 [Abstract] [Full Text] [Related]
20. Portal pressure response to losartan compared with propranolol in patients with cirrhosis. De BK, Bandyopadhyay K, Das TK, Das D, Biswas PK, Majumdar D, Mandal SK, Ray S, Dasgupta S. Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283 [Abstract] [Full Text] [Related] Page: [Next] [New Search]